Filing Details

Accession Number:
0001127602-12-012009
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-28 13:00:00
Reporting Period:
2012-03-26
Filing Date:
2012-03-28
Accepted Time:
2012-03-28 16:23:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
920148 Laboratory Corp Of America Holdings LH Services-Medical Laboratories (8071) 133757370
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1320940 B William Hayes 531 South Spring Street
Burlington NC 27215
Chief Financial Officer, Evp No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-26 2,750 $70.15 26,828 No 4 M Direct
Common Stock Disposition 2012-03-26 2,750 $90.00 24,078 No 4 S Direct
Common Stock Acquisiton 2012-03-26 23,878 $0.00 47,956 No 4 A Direct
Common Stock Disposition 2012-03-26 10,137 $91.90 37,819 No 4 F Direct
Common Stock Disposition 2012-03-27 13,741 $91.67 24,078 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 A Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Options Disposition 2012-03-26 2,750 $0.00 2,750 $70.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
22,234 2011-02-09 2020-02-09 No 4 M Direct
Footnotes
  1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
  2. Shares granted on March 26, 2012, pursuant to a performance award granted on February 10, 2009, relating to performance during the three year period ended December 31, 2011.
  3. Stock withholding to satisfy tax and withholding obligations.
  4. The price of $91.6663 per share represents a weighted average of sales prices ranging from $91.34 to $92.08 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
  5. Common stock purchase option granted under the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
  6. The option vests in three equal annual installments beginning on the date reflected in this column.